I
REGN icon

InceptionR’s Regeneron Pharmaceuticals REGN Stock Holding History

InceptionR’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685K Buy
+887
New +$679K 0.17% 213
2025
Q4 		– Sell
-390
Closed -$219K – 830
2025
Q3 		$219K Sell
390
-234
-38% -$132K 0.05% 580
2025
Q2 		$328K Buy
+624
New +$348K 0.08% 428
2024
Q2 		– Sell
-1,792
Closed -$1.72M – 810
2024
Q1 		$1.72M Buy
1,792
+1,244
+227% +$1.18M 0.44% 22
2023
Q4 		$481K Buy
+548
New +$451K 0.34% 112
2023
Q2 		– Sell
-263
Closed -$216K – 589
2023
Q1 		$216K Buy
+263
New +$198K 0.07% 385

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

InceptionR's REGN Position: Q1 2026 in Review

InceptionR opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 887 shares worth $685K. The stake represents 0.17% of the portfolio and ranks #213 among its holdings. This is a return to the name: InceptionR previously reported a position in REGN as recently as Q3 2025.

InceptionR first reported a position in REGN in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.72M in Q1 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • InceptionR held 887 shares of Regeneron Pharmaceuticals worth $685K as of Q1 2026.
  • Regeneron Pharmaceuticals was a new InceptionR position in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.17% of InceptionR's portfolio in Q1 2026, its #213 holding.
  • InceptionR first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • InceptionR's Regeneron Pharmaceuticals position peaked at $1.72M in Q1 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.